Morphic Therapeutic (Waltham, Mass.) raised $80 million on Sept. 25 in a series B round led
Morphic's $80M round paves way for integrin clinical studies
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
Morphic Therapeutic (Waltham, Mass.) raised $80 million on Sept. 25 in a series B round led